EP3129041
DOUBLE-ACYLATED GLP-1 COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.4.2015EP published:
12.6.2019EP application number:
15713772.0
EPO information:
European Patent Register
Max expiry date:
6.4.2035
Title:
DOUBLE-ACYLATED GLP-1 COMPOUNDS
Timeline
Today
7.4.2015EP application
12.6.2019EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
LINDEROTH, LarsAddress:
Bagsværd, DK
Name:
KOFOED, JacobAddress:
Bagsværd, DK
Name:
LAU, JesperAddress:
Bagsværd, DK
Name:
BLOCH, PawAddress:
Bagsværd, DK
Name:
GARIBAY, Patrick WilliamAddress:
Bagsværd, DK
Name:
KODRA, János TiborAddress:
Bagsværd, DK
Priority
Number:
14163697Date:
7.4.2014Country:
EP
Classification
Categories:
A61K 38/26, C07K 14/605